| Synonyms: | |
| Status: | Approved (1999) Withdrawn (2010) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | A10BG02 |
| UNII: | 05V02F2KDG |
| InChI Key | YASAKCUCGLMORW-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H19N3O3S |
| Molecular Weight | 357.44 |
| AlogP | 2.49 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 71.53 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 25.0 |
| Primary Target | |
|---|---|
| Peroxisome proliferator-activated receptor-γ |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Alzheimer Disease | 3 | D000544 | ClinicalTrials |
| Coronary Disease | 3 | D003327 | ClinicalTrials |
| Diabetes Mellitus, Type 2 | 3 | D003924 | ClinicalTrials |
| Prostatic Neoplasms | 3 | D011471 | ClinicalTrials |
| Diabetic Neuropathies | 3 | D003929 | ClinicalTrials |
| Lipid Metabolism Disorders | 3 | D052439 | ClinicalTrials |
| Metabolic Syndrome | 3 | D024821 | ClinicalTrials |
| Multiple Organ Failure | 3 | D009102 | ClinicalTrials |
| Hypertension | 3 | D006973 | ClinicalTrials |
| Metabolic Diseases | 3 | D008659 | ClinicalTrials |
| Glucose Intolerance | 3 | D018149 | ClinicalTrials |
| Atherosclerosis | 3 | D050197 | ClinicalTrials |
| Glucose Intolerance | 3 | D018149 | ClinicalTrials |
| Hypercholesterolemia | 3 | D006937 | ClinicalTrials |
| Non-alcoholic Fatty Liver Disease | 2 | D065626 | ClinicalTrials |
| Colitis, Ulcerative | 2 | D003093 | ClinicalTrials |
| Prediabetic State | 2 | D011236 | ClinicalTrials |
| Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
| Insulin Resistance | 2 | D007333 | ClinicalTrials |
| HIV Infections | 2 | D015658 | ClinicalTrials |
| Sezary Syndrome | 2 | D012751 | ClinicalTrials |
| Asthma | 2 | D001249 | ClinicalTrials |
| Endometriosis | 2 | D004715 | ClinicalTrials |
| Cognitive Dysfunction | 2 | D060825 | ClinicalTrials |
| Mycosis Fungoides | 2 | D009182 | ClinicalTrials |
| Erectile Dysfunction | 1 | D007172 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Malaria | 1 | D008288 | ClinicalTrials |
| Anemia | 1 | D000740 | ClinicalTrials |
| Nausea | 1 | D009325 | ClinicalTrials |
| Glomerulosclerosis, Focal Segmental | 1 | D005923 | ClinicalTrials |
| Breast Neoplasms | 1 | D001943 | ClinicalTrials |
| Malaria, Falciparum | 1 | D016778 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 122320-73-4 |
| ChEBI | 50122 |
| ChEMBL | CHEMBL121 |
| DrugBank | DB00412 |
| DrugCentral | 2405 |
| EPA CompTox | DTXSID7037131 |
| FDA SRS | 05V02F2KDG |
| Human Metabolome Database | HMDB0005031 |
| Guide to Pharmacology | 1056 |
| PharmGKB | PA451283 |
| PubChem | 77999 |
| SureChEMBL | SCHEMBL5169 |